Researchers Submit Patent Application, "Multi-Armed Myxoma Virus", for Approval (USPTO 20240092852).

A patent application has been submitted for a "Multi-Armed Myxoma Virus" that could potentially improve cancer treatments. The application describes a genetically engineered virus that includes specific proteins to disrupt certain genes and enhance its anti-cancer properties. The application provides detailed information on the structure and composition of the virus. The genetically engineered virus has shown reduced expression of certain proteins in infected cells compared to control viruses. [Extracted from the article]